In-vitro activity of azithromycin against Chlamydia trachomatis

Journal of Antimicrobial Chemotherapy

Volumn 25, Issue , 1990, Pages 7-10

  Scieux, C ^a   Bianchi, A ^a   Chappey, B ^a   Vassias, I ^a   Perol Y ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENOMYL; DOXYCYCLINE; ERYTHROMYCIN;

ANTIMICROBIAL ACTIVITY; BACTERIUM ISOLATION; CHLAMYDIA TRACHOMATIS; CONFERENCE PAPER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

AZITHROMYCIN; CHLAMYDIA TRACHOMATIS; COMPARATIVE STUDY; DOXYCYCLINE; ERYTHROMYCIN; HELA CELLS;

EID: 0025166660     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/25.suppl_A.7     Document Type: Article

References (13)

1. Asche, V. & Hutton, S. (1988). Sensitivity testing of Chlamydia trachomatis. In Proceedings of the European Society for Chlamydia Research, Bologna, Italy, 1988. Abstract 283.
2. Barry, A. L., Jones, R. N. & Thomsberry, C. (1988). In vitro activities of azithromycin (CP- 62, 993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. Antimicrobial Agents and Chemotherapy 32, 752–754.
3. Bianchi, A., Scieux, C., Salmeron, C. M., Casin, I. & Perol, Y. (1988). Rapid determination of MICs of 15 antimicrobial agents by using an enzyme immunoassay (Chlamydiazyme). Antimicrobial Agents and Chemotherapy 32, 1350–1353.
4. Bowie, W. R., Shaw, C. E., Chan, D. G. W. & Black, W. A. (1987). In vitro activity of RO 15–8074, RO19–5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 31, 470–472.
5. Cevenini, R., Sambri, V. & La Placa, M. (1986). Comparative in-vitro activity of RU 28965 against Chlamydia trachomatis. European Journal of Clinical Microbiology 5, 598–600.
6. Ehret, J. M. & Judson, F. N. (1988). Susceptibility testing of Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 32, 1295–1299.
7. Girard, A. E., Girard, D., English, A. R., Gootz, T. D., Cimochowski, C. R., Faiella, J. A. et al. (1987). Pharmacokinetic and in vivo studies with azithromycin (CP-62, 993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrobial Agents and Chemotherapy 31, 1948–1954.
8. Lee, C. K., Bowie, W. R. & Alexander, E. R. (1978). In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation. Antimicrobial Agents and Chemotherapy 13, 441–445.
9. Mourad, A., Sweet, R. L., Sugg, N. & Schachter, J. (1980). Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 18, 696–8.
10. Ridgway, G. L. (1986). Antimicrobial chemotherapy of chlamydial infection: Where next? European Journal of Clinical Microbiology 5, 550–553.
11. Ridgway, G. L., Owen, J. M. & Oriel, J. D. (1978). The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. British Journal of Venereal Diseases 54, 103–106.
12. Segreti, J., Kessler, H. A., Kapell, K. S. & Trenholme, G. M. (1987). In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 31, 100–101.
13. Walsh, M., Kappus, E. W. & Quinn, T. C. (1987). In-vitro evaluation of CP-62, 993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 31, 811–812.